Latest news

October 6, 2020

Immunexpress’ rapid test for sepsis launched in Europe on Biocartis’ Idylla platform

September 9, 2020

Debiopharm co-leads an investment round of €10 million in Oncomfort

July 7, 2020

Debiopharm invests in NucleAI– using AI to develop digital pathology biomarkers

June 19, 2020

Debiopharm and Ipsen Win the 2020 ASAP Alliance Excellence Awards

June 17, 2020

Immunexpress awarded funding to develop their COVID-19 patient triage test SeptiCyte® RAPID

May 26, 2020

Acquisition of Kaiku Health by the swedish company Elekta

May 20, 2020

BC Platforms Honored by Microsoft for their Efforts to “Reimagine Health” with Kaiser Permanente

April 21, 2020

Knight Therapeutics Inc commercializes Trelstar® in Canada

April 15, 2020

Kaiku Health and the Geneva University Hospitals implement digital symptom monitoring for COVID-19 patients in Switzerland